Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Microbix Biosystems Inc (MBXBF)

Microbix Biosystems Inc (MBXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Microbix Announces Annual Meeting Voting Results ACCESS Newswire - Thu Mar 26, 2:00AM CDT

MISSISSAUGA, ON / ACCESS Newswire / March 26, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQB:MBXBF) ("Microbix®" or the Company"), a life sciences innovator, manufacturer, and exporter, announces the...

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Presents Reference-Material Innovations at EUROGIN ACCESS Newswire - Tue Mar 17, 2:00AM CDT

QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix's Clot-Buster Drug Project Advances ACCESS Newswire - Tue Mar 10, 2:00AM CDT

Drug Substance Manufacturing Methods Modernized

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Announces Issuance of Stock Options ACCESS Newswire - Tue Feb 24, 1:00AM CST

Using Shareholder-Approved Plan to Incentivize and Retain

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Reports Results for Q1 2026 ACCESS Newswire - Thu Feb 12, 1:20AM CST

Q1 Revenues of $4.2 million and Controlled Net Loss

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs ACCESS Newswire - Tue Feb 10, 1:00AM CST

MISSISSAUGA, ON / ACCESS Newswire / February 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, is pleased to welcome the College...

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Schedules Release of Results for Q1 Fiscal 2026 ACCESS Newswire - Thu Feb 5, 1:00AM CST

Results Release and Webinar Discussion on Morning of February 12, 2026

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Presents Molecular Pathology Platform Results ACCESS Newswire - Wed Feb 4, 1:00AM CST

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Updates Investor Presentation on its Website ACCESS Newswire - Fri Jan 9, 1:00AM CST

In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure)

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing ACCESS Newswire - Wed Jan 7, 1:00AM CST

MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage...

MBX.TO : 0.2250 (-2.17%)
MBXBF : 0.1715 (+3.75%)

Barchart Exclusives

Oil Price Predictions Surge to $200 a Barrel as the Strait of Hormuz Blockage Drags On Barchart - 14 minutes ago
Discussion of a recent analyst perspective on the price of oil increasing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.